The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
about
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroidLong-acting beta2-agonists for stable chronic asthmaComparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysisUtilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.Performing a lung disability evaluation: how, when, and why?Interaction and dose equivalence of salbutamol and salmeterol in patients with asthmaDose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover studyChanges in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.A one-week dose-ranging study of inhaled salmeterol in children with asthma.Salmeterol: a novel, long-acting beta 2-agonist.Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products.Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects.Methacholine challenge testing: comparative pharmacology.Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients
P2860
Q24246441-FE095458-EC31-4E27-87D8-6420B294A841Q24247926-FAE43405-AD9C-45F3-8E50-1A16367D9672Q26781071-B2D6BF6E-E85F-4F58-9EED-24D833758D98Q33928874-570C1847-7981-45A9-AAEB-C9659B3F68DBQ34872797-3AA92F30-B572-4796-AB99-90C6DC120B27Q35187262-3775DDA6-6BBC-417D-B0BE-D367805B9B57Q35563253-149C006F-C7B2-489B-A580-AAF7756C997FQ35627925-BC3D3C61-21CE-40C0-9BD8-4E498AB25ACEQ35826407-2BD498B8-07F7-411E-918A-928A96D2EF50Q36289816-5580E303-3269-4565-9693-DB9C9B3C1BEBQ39459568-7A583907-A89E-4346-B3CB-248C862E8975Q40620716-14E2D6AD-0623-43BC-8550-4829C659A67BQ40713319-1B07EDE0-B7AD-4DE7-9C85-9611B36180A6Q42593035-2AAA887F-0C8A-4E2A-A96C-B7348EC47693Q43584756-E25B5431-CA17-4042-AF86-F280830D20FDQ43796660-BE2BF1F6-7899-4263-ADE9-0EE6D5167D79Q51246235-08FFF339-EF2B-468A-87D2-C4855648AB57Q55233920-75486FB0-3CD5-43BA-835B-48D8211897C7Q57085060-B52FB77B-97F4-42AB-824A-AD7FB60B2B91
P2860
The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@en
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@nl
type
label
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@en
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@nl
prefLabel
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@en
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@nl
P2093
P1476
The effect of inhaled salmeter ...... ts with asthma up to 12 hours.
@en
P2093
Pauwels RA
Van der Straeten ME
P304
P356
10.1016/0091-6749(92)90435-5
P407
P577
1992-04-01T00:00:00Z